Welcome to this conference review of the Joint Scientific Meeting of HSANZ (Haematology Society of Australia and New Zealand), ANZSBT (Australian and New Zealand Society of Blood Transfusion) and ASTH (Australasian Society of Thrombosis and Haemostasis).

Selection and review of the research has been carried out independently by Drs Jane Gordon, from the Centenary Institute, and Matthew Wright, from the Royal Perth Hospital, both of whom attended HAA 2013.

In this Issue:

Post-ASCT survival with thalidomide consolidation in MM
Leucodepletion reduces morbidity, not mortality
In vivo kinase inhibition with nilotinib
‘Fast track’ warfarin reversal
Management of primary CNS lymphoma
Spinal MRI in newly diagnosed myeloma
Update on DLI use
Genome sequencing methodologies
Using JAK inhibitors for myelofibrosis
Fibrinogen concentrates/transfusions in major bleeding
New oral anticoagulants
Preparedness for customised CML therapy
Blinatumomab for B-precursor ALL
Inducible caspase 9 for adoptive T-cell therapy

Please login below to download this issue (PDF)

Subscribe